EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Cannabidiol and microRNAs: shared cellular targets and new insights for developing anti-seizure modalities

Arya Afrooghe iD, Elham Ahmadi iD, Maryam Shayan iD, Mohammad Amin Dabbagh Ohadi iD, Amir Hossein Behnoush iD, Ahmad Reza Dehpour iD

Journal of Pharmacy and Pharmacology · 2025

DOI: 10.1093/jpp/rgaf039 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Pharmacy and Pharmacology, 2025. Verfasst von Arya Afrooghe und 5 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Cannabidiol, MicroRNAs, Anticonvulsants, Seizures. Die Arbeit nennt 99 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cannabidiol (CBD) and 9-tetrahydrocannabinol (THC) are the two main components of cannabis that provide its therapeutic benefits. CBD has been extensively studied for its role in reducing seizures, among its many other uses. While the exact mechanisms by which CBD works to relieve seizures have not yet been fully determined, it is evident that CBD effectively diminishes seizure activity and is now being used as an approved treatment for severe forms of non-responsive epilepsy. As essential components of several biological processes, microRNAs (miRNAs) are crucial for achieving optimal cellular functioning. During the past few years, there has been an increasing interest in elucidating the functional significance of microRNAs in epilepsy. Yet, there is still considerable ambiguity regarding the precise mechanisms by which miRNAs are involved in seizure disorders and also their direct interaction with CBD. Herein, we seek to present an overview of the varying mechanisms by which CBD offers therapeutic benefits concerning seizures. Accordingly, we highlighted the shared molecular targets between microRNAs and CBD in alleviating seizure symptoms to shed light on the ways in which new therapeutic and diagnostic modalities could be shaped in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabidiolMicroRNAsAnticonvulsantsSeizuresEpilepsyHumansAnimalsCannabis

Stichwörter der Autor:innen

cannabidiolcannabisepilepsymicroRNAseizure

Substanzen

CannabidiolMicroRNAsAnticonvulsants

Autor:innen und Institutionen

  • Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Schepens Eye Research Institute, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Department of Ophthalmology, 20 Staniford St., Boston, MA 02114, United States.
  • Neurosurgery Department, Imam Khomeini Hospital Complex (IKHC), Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Arya Afrooghe, Elham Ahmadi, Maryam Shayan, Mohammad Amin Dabbagh Ohadi, Amir Hossein Behnoush, Ahmad Reza Dehpour

Zitieren

APA

Afrooghe, A., Ahmadi, E., Shayan, M., Dabbagh Ohadi, M. A., Behnoush, A. H., & Dehpour, A. R. (2025). Cannabidiol and microRNAs: shared cellular targets and new insights for developing anti-seizure modalities. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgaf039

Vancouver

Afrooghe A, Ahmadi E, Shayan M, Dabbagh Ohadi MA, Behnoush AH, Dehpour AR. Cannabidiol and microRNAs: shared cellular targets and new insights for developing anti-seizure modalities. Journal of Pharmacy and Pharmacology. 2025. doi:10.1093/jpp/rgaf039

BibTeX
@article{Afrooghe2025,
  author = {Afrooghe, Arya and Ahmadi, Elham and Shayan, Maryam and Dabbagh Ohadi, Mohammad Amin and Behnoush, Amir Hossein and Dehpour, Ahmad Reza},
  title = {Cannabidiol and microRNAs: shared cellular targets and new insights for developing anti-seizure modalities},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2025},
  doi = {10.1093/jpp/rgaf039}
}
Kostenlos starten →